Dalbergioidin Ameliorates Doxorubicin-Induced Renal Fibrosis by Suppressing the TGF-β Signal Pathway

Figure 1

Kidney injury at 5 weeks after DXR injection in different groups of mice as indicated. (a) Effect of DAL on albuminuria against DXR-induced nephrotoxicity; (b) effect of DAL on hyperlipidemia against DXR-induced nephrotoxicity; (c) effect of DAL on blood urea nitrogen (BUN) against DXR-induced nephrotoxicity; (d) effect of DAL on serum creatinine against DXR-induced nephrotoxicity. The control and DAL treatment groups are compared with the DXR group. Values are statistically significant at ; the DXR group is compared with the control group. Values are statistically significant at .

(a)

(b)

(c)

(d)